Search

Author/Creator Guren, T K

1. 1172PA first-in-class, first-in-human phase I/IIa trial of CAN04, targeting interleukin-1 receptor accessory protein (IL1RAP), in patients with solid tumors. (23rd October 2018)

Authors:
Awada, A; Eskens, F A L M; Robbrecht, D G; Lassen, U N; Sorensen, M; Schellens, J H M; de Groot, J S; Jungels, C; Aftimos, P G; Fretland, S O; Thorsson, L; Guren, T K
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 8
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 569PISO-CC-005; A phase I/II study of arfolitixorin (MTHF) in combination with 5-FU, irinotecan, and oxaliplatin ± bevacizumab in patients with metastasizing colorectal cancer. (23rd October 2018)

Authors:
Carlsson, G U; Guren, T K; Haux, J; Pfeiffer, P; Taflin, H; Mavroudis, D; Georgoulias, V; Papadimitriou, C; Kentepozidis, N; Boumpas, D; Skintemo, L; Ganlöv, K M E; Gustavsson, B
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 8
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗